David Backer joined Curate Biosciences in January 2023 as CEO, bringing his deep industry experience to drive the commercial launch and growth of the Company. Backer previously served as Chief Commercial Officer at Oxford Biomedica, and prior to that, was Senior Vice President, Commercial Development at cell and gene therapy-enabling tech company ElevateBio.
He also founded and led the successful sale of Molecular Medicine BioServices to Sigma-Aldrich's SAFC division, leading to an extensive career at Sigma-Aldrich SAFC and MilliporeSigma. He completed his tenure at MilliporeSigma as Head of Commercial Development for Gene Editing and Novel Modalities.
He earned his MBA from the University of Chicago and a BS in Cellular and Molecular Biology at the University of Michigan.
He also founded and led the successful sale of Molecular Medicine BioServices to Sigma-Aldrich's SAFC division, leading to an extensive career at Sigma-Aldrich SAFC and MilliporeSigma. He completed his tenure at MilliporeSigma as Head of Commercial Development for Gene Editing and Novel Modalities.
He earned his MBA from the University of Chicago and a BS in Cellular and Molecular Biology at the University of Michigan.
Speaking In
5:15 PM - 5:30 PM
Monday, June 5
